tiprankstipranks
Innexus Biotechnology Inc (IXSBF)
OTHER OTC:IXSBF
US Market

Innexus Biotechnology (IXSBF) Income Statement

1 Followers

Innexus Biotechnology Income Statement

Last quarter (Q ), Innexus Biotechnology's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q, Innexus Biotechnology's net income was C$-555.94K. See Innexus Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 10Jun 09Jun 08Jun 07Jun 06
Total Revenue
-C$ 0.00C$ 0.00C$ 1.01KC$ 15.27KC$ 46.36K
Cost of Revenue
-C$ 0.00C$ 0.00C$ 0.00--
Gross Profit
-C$ 0.00C$ 0.00C$ 1.01K--
Operating Expense
C$ 2.27MC$ 3.93MC$ 6.70MC$ 5.71MC$ 5.79MC$ 2.72M
Operating Income
C$ -2.27MC$ -3.93MC$ -6.70MC$ -5.71MC$ -5.77MC$ -2.67M
Net Non Operating Interest Income Expense
C$ -2.13MC$ -2.79MC$ -1.31MC$ -175.41K--
Other Income Expense
C$ 155.28KC$ 34.13KC$ -3.88KC$ 2.71MC$ 638.73KC$ -86.83K
Pretax Income
------
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -4.24MC$ -6.69MC$ -8.02MC$ -5.89MC$ -5.17MC$ -2.93M
Basic EPS
C$ -0.04C$ -0.07C$ -0.11C$ -0.11C$ -0.13C$ -0.12
Diluted EPS
C$ -0.04C$ -0.07C$ -0.11C$ -0.11C$ -0.13C$ -0.12
Basic Average Shares
C$ 551.16MC$ 96.34MC$ 75.29MC$ 55.26MC$ 43.94MC$ 25.01M
Diluted Average Shares
C$ 551.16MC$ 96.34MC$ 75.29MC$ 55.26MC$ 43.94MC$ 25.01M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 2.27MC$ 3.93MC$ 6.70MC$ 5.71MC$ 5.79MC$ 2.72M
Net Income From Continuing And Discontinued Operation
C$ -4.24MC$ -6.69MC$ -8.02MC$ -5.89MC$ -5.17MC$ -2.93M
Normalized Income
C$ -4.24MC$ -6.69MC$ -8.01MC$ -5.89MC$ -5.81MC$ -2.93M
Interest Expense
C$ 2.13MC$ 2.79MC$ 1.31MC$ 252.66K--
EBIT
C$ -2.27MC$ -3.93MC$ -6.70MC$ -5.71MC$ -5.77MC$ -2.67M
EBITDA
C$ -1.37MC$ -2.94MC$ -6.29MC$ -5.21MC$ -5.50MC$ -2.48M
Currency in CAD

Innexus Biotechnology Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis